Keywords
Last Name
Institution

Sucharita Mistry

TitleASSISTANT PROFESSOR
InstitutionMount Sinai
DepartmentHematology and Medical Oncology
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Mistry SJ, Oh WK. New paradigms in microtubule-mediated endocrine signaling in prostate cancer. Mol Cancer Ther. 2013 May; 12(5):555-66.
      View in: PubMed
    2. Miceli C, Tejada A, Castaneda A, Mistry SJ. Cell cycle inhibition therapy that targets stathmin in in vitro and in vivo models of breast cancer. Cancer Gene Ther. 2013 May; 20(5):298-307.
      View in: PubMed
    3. Scher BM, Mistry SJ, Haque NS, Scher W. Isolation and characterization of a large soluble form of fibronectin that stimulates adhesion, spreading, and alignment of mouse erythroleukemia cells. Exp Cell Res. 2010 Sep 10; 316(15):2402-13.
      View in: PubMed
    4. Mistry SJ, Bank A, Atweh GF. Synergistic antiangiogenic effects of stathmin inhibition and taxol exposure. Mol Cancer Res. 2007 Aug; 5(8):773-82.
      View in: PubMed
    5. Mistry SJ, Atweh GF. Therapeutic interactions between stathmin inhibition and chemotherapeutic agents in prostate cancer. Mol Cancer Ther. 2006 Dec; 5(12):3248-57.
      View in: PubMed
    6. Mistry SJ, Bank A, Atweh GF. Targeting stathmin in prostate cancer. Mol Cancer Ther. 2005 Dec; 4(12):1821-9.
      View in: PubMed
    7. Mistry SJ, Atweh GF. Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy. Mt Sinai J Med. 2002 Oct; 69(5):299-304.
      View in: PubMed
    8. Mistry SJ, Atweh GF. Stathmin inhibition enhances okadaic acid-induced mitotic arrest: a potential role for stathmin in mitotic exit. J Biol Chem. 2001 Aug 17; 276(33):31209-15.
      View in: PubMed
    9. Iancu C, Mistry SJ, Arkin S, Wallenstein S, Atweh GF. Effects of stathmin inhibition on the mitotic spindle. J Cell Sci. 2001 Mar; 114(Pt 5):909-16.
      View in: PubMed
    10. Mistry SJ, Benham CJ, Atweh GF. Development of ribozymes that target stathmin, a major regulator of the mitotic spindle. Antisense Nucleic Acid Drug Dev. 2001 Feb; 11(1):41-9.
      View in: PubMed
    11. Iancu C, Mistry SJ, Arkin S, Atweh GF. Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle. Cancer Res. 2000 Jul 1; 60(13):3537-41.
      View in: PubMed
    12. Mistry SJ, Atweh GF. Stathmin expression in immortalized and oncogene transformed cells. Anticancer Res. 1999 Jan-Feb; 19(1A):573-7.
      View in: PubMed
    13. Mistry SJ, Li HC, Atweh GF. Role for protein phosphatases in the cell-cycle-regulated phosphorylation of stathmin. Biochem J. 1998 Aug 15; 334 ( Pt 1):23-9.
      View in: PubMed
    14. Luo XN, Mookerjee B, Ferrari A, Mistry S, Atweh GF. Regulation of phosphoprotein p18 in leukemic cells. Cell cycle regulated phosphorylation by p34cdc2 kinase. J Biol Chem. 1994 Apr 8; 269(14):10312-8.
      View in: PubMed
    Mistry's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067